Jade Biosciences, Inc.
JBIO
$8.03
$0.131.65%
NASDAQ
| 06/30/2025 | |||||
|---|---|---|---|---|---|
| Net Income | 15.81% | ||||
| Total Depreciation and Amortization | -137.50% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -43.03% | ||||
| Change in Net Operating Assets | 15.43% | ||||
| Cash from Operations | -7.47% | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -- | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -1,856.00% | ||||
| Cash from Financing | 27,429.71% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 978.93% | ||||